BioVie’s NE3107 Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients in Dat

Go back to BioVie’s NE3107 Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients in Dat
(NASDAQ: BIVI) Delayed: 1.92 --0 (-0%)
Previous Close $1.92    52 Week High $0.40 
Open $1.92    52 Week Low $0.17 
Day High $1.92    P/E N/A 
Day Low $1.92    EPS $0.00 
Volume 51